(SKS) downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. Expect difficult environment for high-end retain in the second half of the year. $9 price target.
STOCK COMMENTS / EPS CHANGES
(CAT - Get Report)
estimates, target cut at Credit Suisse. CAT estimates were reduced through 2014, Credit Suisse said. Dealer survey suggests lower potential growth. Outperform rating and new $120 price target.
(CBSH) numbers raised at UBS. Shares of CBSH now seen reaching $41, UBS said. Estimates also raised on better than expected loan growth. Neutral rating.
(CSCO - Get Report) estimates, target lowered at Sterne Agee. Shares of CSCO now seen reaching $23, according to Sterne Agee. Estimates also cut, given macro headwinds. Buy rating.
(FFIV - Get Report) numbers cut at ThinkEquity. Shares of FFIV now seen reaching $122, according to ThinkEquity. Estimates also reduced, given macro concerns. Buy rating.
estimates lowered at Oppenheimer through 2014, Oppenheimer said. Lowers outlook and cites pricing/realization pressure. Perform rating.
numbers reduced at Bernstein. NDAQ estimates were cut through 2013, Bernstein said. Volumes have been lighter than expected. Hold rating and new $25 price target.
Scotts Miracle Gro
estimates lowered at Oppenheimer through 2013 to reflect drought, Oppenheimer said. Perform rating.
numbers reduced at Credit Suisse. Shares of TSCO now seen reaching $81, according to Credit Suisse. Estimates also cut, given lower expected farm spending. Neutral rating.
estimates lowered at UBS through 2013 based on field checks, UBS said. $125 price target and Buy rating.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts